Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

China Allows Importation of "Small" Amounts of Non-China-Approved Drugs

publication date: Aug 26, 2019

In a new ruling, China has decided to allow the importation of small amounts of drugs that are not approved in China but are legal elsewhere. According to a Reuters report, the change was designed to help China patients who are unable to buy China-approved foreign drugs because of their cost. Reuters attributed the change to a movie “Dying To Survive,” which caused outrage. It was based on the real story of a China leukemia patient who was jailed for importing an India generic to a more expensive treatment from Novartis. More details...

Stock Symbol: (NYSE: NVS)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China